These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12518340)

  • 1. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
    Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
    J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.
    Petroianu G; Kühn F; Arafat K; Zuleger K; Missler A
    J Appl Toxicol; 2004; 24(2):143-6. PubMed ID: 15052610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
    Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
    J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
    Petroianu GA; Schmitt A; Arafat K; Hasan MY
    Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
    Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
    J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide protection of cholinesterase from paraoxon inhibition.
    Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
    Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
    Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pyruvic acid application in minipigs partially protects acetylcholine-esteratic but not butyrylcholine-esteratic activity in plasma from inhibition by paraoxon.
    Petroianu GA; Ewald V; Thyes C; Missler A; Maleck WH
    J Appl Toxicol; 2003; 23(1):37-42. PubMed ID: 12518335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of metoclopramide against organophosphate-induced apoptosis in the murine skin fibroblast L929.
    Jaber BM; Petroianu GA; Rizvi SA; Borai A; Saleh NA; Hala SM; Saleh AM
    J Appl Toxicol; 2018 Mar; 38(3):329-340. PubMed ID: 29027213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
    J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pralidoxime inhibits paraoxon-induced depression of rocuronium-neuromuscular block in a time-dependent fashion.
    Narimatsu E; Niiya T; Takahashi K; Yamauchi M; Yamakage M
    Am J Emerg Med; 2012 Jul; 30(6):901-7. PubMed ID: 21871755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.